CLINICAL_TRIALS
trial_result
· 2011-01-27
Clinical Trial Update: Efalizumab to Treat Uveitis [Phase 1]
Summary
Phase 1 trial of efalizumab for uveitis (with macular edema) completed; results posted January 27, 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Eye Institute (NEI) | Conditions: Uveitis, Macular Edema | Phase 1 | Status: COMPLETED | Results posted: 2011-01-27